UCBB (US-China Biomedical Technology) Market Cap : $0.00 Mil (As of Apr. 27, 2025)

View and export this data going back to 2011. Start your Free Trial

What is US-China Biomedical Technology Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). US-China Biomedical Technology's share price for the quarter that ended in May. 2019 was $0.04. US-China Biomedical Technology's Shares Outstanding (EOP) for the quarter that ended in May. 2019 was 19.80 Mil. Therefore, US-China Biomedical Technology's market cap for the quarter that ended in May. 2019 was $0.79 Mil.

US-China Biomedical Technology's quarterly market cap declined from Nov. 2018 ($4.50 Mil) to Feb. 2019 ($3.88 Mil) and declined from Feb. 2019 ($3.88 Mil) to May. 2019 ($0.79 Mil).

US-China Biomedical Technology's annual market cap declined from Feb. 2017 ($14.72 Mil) to Feb. 2018 ($8.51 Mil) and declined from Feb. 2018 ($8.51 Mil) to Feb. 2019 ($3.88 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. US-China Biomedical Technology's Enterprise Value for Today is $0.00 Mil.

US-China Biomedical Technology Market Cap Historical Data

The historical data trend for US-China Biomedical Technology's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

US-China Biomedical Technology Market Cap Chart

US-China Biomedical Technology Annual Data

Trend

Feb12

Feb13

Feb14

Feb15

Feb16

Feb17

Feb18

Feb19

Market Cap

Get a 7-Day Free Trial

18.24

64.35

14.72

8.51

3.88

US-China Biomedical Technology Quarterly Data
	Aug14	Nov14	Feb15	May15	Aug15	Nov15	Feb16	May16	Aug16	Nov16	Feb17	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19
Market Cap	Get a 7-Day Free Trial															11.63	2.33	4.50	3.88	0.79

Competitive Comparison of US-China Biomedical Technology's Market Cap

For the Health Information Services subindustry, US-China Biomedical Technology's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

US-China Biomedical Technology's Market Cap Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, US-China Biomedical Technology's Market Cap distribution charts can be found below:

* The bar in red indicates where US-China Biomedical Technology's Market Cap falls into.

Save Embed

;

Save Embed

;

US-China Biomedical Technology Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

US-China Biomedical Technology's Market Cap for the fiscal year that ended in Feb. 2019 is calculated as

Market Cap (A: Feb. 2019 )	=	Share Price (A: Feb. 2019 )	*	Shares Outstanding (EOP) (A: Feb. 2019 )
	=	$0.25	*	15.511
	=	$3.88

US-China Biomedical Technology's Market Cap for the quarter that ended in May. 2019 is calculated as

Market Cap (Q: May. 2019 )	=	Share Price (Q: May. 2019 )	*	Shares Outstanding (EOP) (Q: May. 2019 )
	=	$0.04	*	19.801
	=	$0.79

US-China Biomedical Technology (GREY:UCBB) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

US-China Biomedical Technology Market Cap Related Terms

Thank you for viewing the detailed overview of US-China Biomedical Technology's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

US-China Biomedical Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » US-China Biomedical Technology Inc (GREY:UCBB) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Park Plaza, Suite 400, Irvine, CA, USA, 92614

Website

https://www.ucbb.us

US-China Biomedical Technology Inc is an early stage biomedical technology and services company. It is engaged in the integration and development of synergistic relationships with high profiled doctors and hospitals that will act as a bridge for connecting patients and bio-technology advances in China with its network of US based doctors and hospitals. It provides services for moving patients from China to the US with an emphasis on the demographics including pre-screening and genetic testing for family members of cancer patients, patients suffering from Diabetes, and general medical services including preventative care and physicals.

US-China Biomedical Technology Headlines

No Headlines